Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial
Title:
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial
Author:
Sellier-Leclerc, Anne-Laure Magen, Daniella Shasha-Lavsky, Hadas Simkova, Eva Devresse, Arnaud Guebre-Egziabher, Fitsum Michael, Mini Lieske, John C. Frishberg, Yaacov Bakkaloglu, Sevcan A. Mourani, Chebl Saqan, Rola Singer, Richard Guzzo, Isabella Makarova, Nune Willey, Richard Kaspar, Cristin Gansner, John M. Groothoff, Jaap W.